Taysha Gene Therapies: Q4 Earnings Insights

Taysha Gene Therapies TSHA reported its Q4 earnings results on Tuesday, March 19, 2024 at 04:01 PM.

Here's what investors need to know about the announcement.

Taysha Gene Therapies beat estimated earnings by 936.0%, reporting an EPS of $0.92 versus an estimate of $-0.11.

Revenue was up $1.10 million from the same period last year.

Last quarter the company missed on EPS by $0.76 which was followed by a 26.0% increase in the share price the next day.

Here's a look at Taysha Gene Therapies's past performance:

Quarter	Q3 2023	Q2 2023	Q1 2023	Q4 2022
EPS Estimate	-0.17	-0.31	-0.35	-0.33
EPS Actual	-0.93	-0.38	-0.28	-0.34
Revenue Estimate	1.40M	2.00M	70K	8.18M
Revenue Actual	4.75M	2.40M	4.71M	2.50M

To track all earnings releases for Taysha Gene Therapies visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings Calendar